Research Newsletter - August 2006

Spotlighted Research

In a paper published in the scientific journal Development, HSCI's Tissue Differentiation and Cell Fate Program Leader, Andy McMahon and Stephen Rodda in the Department of Molecular and Cellular Biology, define for the first time the role played by two important morphogens, Hedgehog and Wnt, in the creation of bone forming osteoblasts.

Bad to the Bone: Unlocking the Molecular Regulation of Osteoblast Differentiation and Bone Synthesis
by Stephen Rodda and Andy McMahon

The mammalian skeleton is important for many physiological functions; as a scaffold, it supports the body, enabling motion and mechanical loading, and it provides protection for the internal organs. The bones also provide a niche for postnatal hematopoiesis and are the central store for calcium. As such, any modulation in skeletal strength or integrity, such as that experienced through injury (e.g., fracture) or disease state (e.g., osteoporosis) can severely compromise the quality of life and survival of all vertebrates.

While there are several cell lineages contributing to the skeleton during development, each gives rise to a common bone-generating cell type, the osteoblast. Despite the commonality of this cell type to all bone formation, bone can be produced by two distinct mechanisms: direct differentiation from the mesenchymal progenitor (occurring in the skull and face, called intramembranous ossification) or the formation of bone on a cartilage scaffold (called endochondral ossification, used by the rest of the skeleton).

Endochondral ossification, the focus of our current study, is initiated by the condensation of multipotent mesenchymal progenitor cells into structures that anticipate elements of the adult skeleton. Chondrocytes are the first cell type to form, starting out as immature proliferative cells, which initiate the formation of the cartilage matrix, then differentiating to postmitotic hypertrophic chondrocytes. Osteoblast progenitor cells are first evident in the inner layer of perichondral cells, which lie adjacent to the zone of hypertrophic chondrocytes.

Several lines of evidence implicate Hedgehog (Hh) and canonical Wnt signaling in the regulation of endochondral ossification. Indian hedgehog (Ihh) is expressed by prehypertrophic chondrocytes and acts directly on perichondrial mesenchyme to initiate an osteogenic program. Several recent developmental studies have suggested that canonical Wnts play a role in specification of osteoblasts. Specifically, Cre recombinase expressed under the control of promoters that are active broadly during skeletal development have been used to conditionally inactivate b-catenin function, resulting in an overall failure to develop bone. Despite a common result, these studies disagreed with respect to where along the osteoblast lineage canonical Wnt signaling functions and whether it acts directly.

In this study, we used a broad acting Cre mouse line, Col2cre, to remove b-catenin function in both the chondrocyte lineage and osteoblast lineage, permitting the detailed characterization of where along the osteoblast lineage these cells arrest. While mutant embryos failed to produce terminally differentiated osteoblasts, they were able to produce osteoblast precursor cells that express Osx1, suggesting a role for canonical Wnt downstream of Osx1. To test this hypothesis we generated a novel Osx1-GFP::Cre mouse strain, where Cre expression is restricted to the osteoblast lineage. Using this mouse line to remove b-catenin function resulted in a phenotype consistent with the Col2cre removal of b-catenin function, demonstrating that canonical Wnt functions directly on the osteoblast lineage and downstream of Osx1 expression. Interestingly, cell fate analysis demonstrates that on removal of b-catenin activity, Osx1 expressing osteoblast precursors give rise to ectopic chondrocytes instead of osteoblasts. This suggests that, along with earlier reports, there is an extended role for canonical Wnt signaling in suppression of an alternate chondrocytic fate within osteoblast precursors. In contrast to loss-of-function studies, use of the Osx1-GFP::Cre line to enhance b-catenin activity rapidly accelerated this program, leading to a dramatic expansion of osteoblast precursors and the premature synthesis of a mineralized bone matrix in the long bones.

Finally, using the Osx1-GFP::Cre line, we were able to conditionally block the ability of osteoblast precursors to respond to a Hh signal, demonstrating that once osteoblast progenitor cells reach an Osx1 state, Hh signaling is dispensable for the rest of terminal differentiation.

Overall, this study has defined the precise states of cell differentiation along the osteoblast lineage that Hh and canonical Wnt function, and importantly identified canonical Wnt as a key mediator in the regulation and onset of mineralized matrix production, both key aspects of bone homeostasis and fracture repair.

Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006 Aug;133(16):3231-44. Read Abstract.

Scientific Papers

Review and Commentary

  • Fleming HE, Scadden DT. Embryonic stem cells make human T cells. Proc Natl Acad Sci USA. 2006 Aug 15;103(33):12213-4. Read Abstract.
  • Rao S, Orkin SH. Unraveling the transcriptional network controlling ES cell pluripotency. Genome Biol. 2006 Aug 30;7(8):230. Read Abstract.
  • Rodolfa KT, Eggan K. A Transcriptional Logic for Nuclear Reprogramming. Cell. 2006 Aug 25;126(4):652-655. Read Abstract.

Blood

  • Honczarenko M, Glodek AM, Swierkowski M, Na IK, Silberstein LE. Developmental stage-specific shift in responsiveness to chemokines during human B-cell development. Exp Hematol. 2006 Aug;34(8):1093-100. Read Abstract.
  • Ricote M, Snyder CS, Leung HY, Chen J, Chien KR, Glass CK. Normal hematopoiesis after conditional targeting of RXR{alpha} in murine hematopoietic stem/progenitor cells. J Leukoc Biol. 2006 Aug 3. Read Abstract.
  • Rocnik JL, Okabe R, Yu JC, Lee BH, Giese N, Schenkein DP, Gilliland DG. Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD. Blood. 2006 Aug 15;108(4):1339-45. Read Abstract.

Cancer

  • Costa DB, Dayaram T, D'Alo F, Wouters BJ, Tenen DG, Meyerson M, Tsao MS, Halmos B. C/EBP alpha mutations in lung cancer. Lung Cancer. 2006 Aug;53(2):253-4. Read Abstract.

Cardiovascular System

  • Weissgerber P, Held B, Bloch W, Kaestner L, Chien KR, Fleischmann BK, Lipp P, Flockerzi V, Freichel M. Reduced Cardiac L-Type Ca2+ Current in Cav{beta}2-/- Embryos Impairs Cardiac Development and Contraction With Secondary Defects in Vascular Maturation. Circ Res. 2006 Aug 31. Read Abstract.

Diabetes

  • Yatoh S, Akashi T, Chan PP, Kaneto H, Sharma A, Bonner-Weir S, Weir GC. NeuroD and reaggregation induce beta-cell specific gene expression in cultured hepatocytes. Diabetes Metab Res Rev. 2006 Aug 21. Read Abstract.

Imaging

  • Chen JW, Querol Sans M, Bogdanov A Jr, Weissleder R. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology. 2006 Aug;240(2):473-81. Read Abstract.
  • Law B, Quinti L, Choi Y, Weissleder R, Tung CH. A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. Mol Cancer Ther. 2006 Aug;5(8):1944-9. Read Abstract.

Immunology

  • Fulci G, Breymann L, Gianni D, Kurozomi K, Rhee SS, Yu J, Kaur B, Louis DN, Weissleder R, Caligiuri MA, Chiocca EA. Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci USA. 2006 Aug 22;103(34):12873-8. Read Abstract.

Nervous System

  • Young-Pearse TL, Ivic L, Kriegstein AR, Cepko CL. Characterization of mice with targeted deletion of glycine receptor alpha 2. Mol Cell Biol. 2006 Aug;26(15):5728-34. Read Abstract.

Renal System

  • De Borst MH, van Timmeren MM, Vaidya VS, Van Dalen MB, Kramer AB, Schuurs TA, Bonventre JV, Navis G, van Goor H. Induction of Kidney injury molecule-1 (Kim-1) in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol. 2006 Aug 8. Read Abstract.
  • Obara T, Mangos S, Liu Y, Zhao J, Wiessner S, Kramer-Zucker AG, Olale F, Schier AF, Drummond IA. Polycystin-2 Immunolocalization and Function in Zebrafish. J Am Soc Nephrol. 2006 Aug 30. Read Abstract.
  • van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol. 2006 Aug;291(2):F456-64. Read Abstract.

Skeletal System

  • Abukawa H, Kaban LB, Williams WB, Terada S, Vacanti JP, Troulis MJ. Effect of interferon-alpha-2b on porcine mesenchymal stem cells. J Oral Maxillofac Surg. 2006 Aug;64(8):1214-20. Read Abstract.

Skin

  • Clark RA, Kupper TS. Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest. 2006 Aug;116(8):2084-7. Read Abstract.

Technology

  • Bublik M, Sercarz JA, Lufkin RB, Polyakov M, Paiva PB, Blackwell KE, Castro DJ, Masterman-Smith M, Paiva MB. Ultrasound-guided laser-induced thermal therapy of malignant cervical adenopathy. Laryngoscope. 2006 Aug;116(8):1507-11. Read Abstract.
  • Murphy GJ, Mostoslavsky G, Kotton DN, Mulligan RC. Exogenous control of mammalian gene expression via modulation of translational termination. Nat Med. 2006 Aug 6. Read Abstract.